News
Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain and peripheral diseases involving the CB1 receptor, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback